The Bull Case For Pfizer (PFE) Could Change Following New COVID And Lyme Vaccine Milestones - Learn Why

Summary

Pfizer has achieved new milestones in its COVID and Lyme vaccine programs that could positively impact the company's investment thesis. The article discusses potential developments in these vaccine candidates without specifying clinical or regulatory details.